Cole Memo

Cole Memo

The Cole Memo was a 2013 memorandum by Deputy Attorney General James M. Cole that articulated federal prosecutorial priorities for marijuana offenses in the United States. It instructed United States Attorneys to focus resources on specified enforcement areas while recognizing state-level regulatory schemes in Colorado (U.S. state), Washington (state), and other jurisdictions that had legalized marijuana. The memorandum intersected with debates involving the Obama administration, the United States Department of Justice, the U.S. Congress, and various state agencies and advocacy groups.

Background

James M. Cole issued the memo during the second term of Barack Obama amid escalating policy shifts after ballot initiatives in Colorado (U.S. state) and Washington (state). The memo followed prior guidance such as the Ogden Memorandum and was informed by reports from the Office of National Drug Control Policy, the Drug Enforcement Administration, and the Federal Bureau of Investigation. National discourse involved actors like Senator Dianne Feinstein, Representative Jared Polis, and advocacy groups including Drug Policy Alliance, National Organization for the Reform of Marijuana Laws, and Marijuana Policy Project. States including Oregon, Alaska, California, Nevada, Massachusetts (state), and Maine were part of a broader trend that implicated the Supreme Court of the United States in potential conflicts over federal supremacy and state criminal statutes.

Contents and Guidance

The memorandum enumerated eight enforcement priorities designed for United States Attorneys and identified areas such as preventing distribution to minors, preventing revenues from going to criminal enterprises, and preventing diversion to states where marijuana remained illegal. It referenced statutory authorities including the Controlled Substances Act and administrative enforcement tools exercised by the Drug Enforcement Administration. The guidance emphasized coordination with state and local law enforcement, state regulatory bodies like the Colorado Department of Revenue, and local prosecutors including Denver District Attorney. It also addressed concerns raised by municipal governments such as the City and County of Denver and tribal authorities including the Navajo Nation.

Legal and Policy Context

The memo operated within a complex federal legal architecture involving the Controlled Substances Act, the Commerce Clause adjudicated by the Supreme Court of the United States in cases such as Gonzales v. Raich, and legislative dynamics in the U.S. Congress involving bills like the H.R. 2306 and riders attached to appropriations such as the Rider provisions. Litigation and challenges implicated circuits like the Ninth Circuit Court of Appeals and the Tenth Circuit Court of Appeals, and influenced litigation strategies by plaintiffs in cases heard before judges in districts including the District of Colorado and the Western District of Washington. Executive-branch actors including Attorney General Eric Holder and later Jeff Sessions engaged with the memo’s approach, while state executives like John Hickenlooper and Jay Inslee responded to federal posture. International considerations involved treaties such as the Single Convention on Narcotic Drugs and diplomatic discussions at entities like the United Nations Commission on Narcotic Drugs.

Reactions and Impact

Reactions spanned elected officials, law enforcement agencies, civil liberties organizations, and businesses. Supporters such as Gavin Newsom and Tom Ammiano praised a less punitive federal posture, while critics like Jeff Sessions and certain state attorneys general argued the memo undermined federal law enforcement. Financial institutions regulated by the Federal Reserve and the Financial Crimes Enforcement Network adjusted compliance policies in response to concerns over money laundering described by the Financial Action Task Force frameworks. Cannabis industry stakeholders including Harborside Health Center and policy analysts at think tanks like the Brookings Institution and the Cato Institute analyzed regulatory effects. Municipalities from Seattle to Portland, Oregon and tribal governments evaluated zoning, taxation, and public health implications with input from public health entities such as the Centers for Disease Control and Prevention and the National Institute on Drug Abuse.

Subsequent Developments and Legacy

In 2018, Attorney General Jeff Sessions rescinded the guidance, prompting renewed debate and litigation; subsequently, Congress considered appropriations riders such as the Cole rider-style provisions and proposals from members including Ro Khanna and Earl Blumenauer. States continued to advance statutory reforms with ballot initiatives in California, Massachusetts (state), Michigan, and Arizona (state), while federal legislative efforts included bills like the Marijuana Opportunity Reinvestment and Expungement Act and proposals to reschedule under the Controlled Substances Act. Academic and policy research at institutions such as Harvard Law School, Yale Law School, and Columbia University examined federalism implications, and advocacy from groups like NORML and Drug Policy Alliance pressed for permanent statutory reforms. The memorandum’s legacy endures in debates over prosecutorial discretion, federalism, and the evolving cannabis regulatory landscape across the United States of America.

Category:United States Department of Justice